Status:
COMPLETED
Study of Aripiprazole in Subjects With Alcoholism
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka America Pharmaceutical
Conditions:
Alcoholism
Eligibility:
All Genders
21-65 years
Phase:
PHASE4
Brief Summary
The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo....
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects with a diagnosis of alcohol dependence who want to stop using alcohol will be considered for the study.
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00082199
Start Date
April 1 2004
End Date
August 1 2005
Last Update
November 11 2013
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Farmington, Connecticut, United States
2
Local Institution
New Haven, Connecticut, United States
3
Local Institution
Indianapolis, Indiana, United States
4
Local Institution
Boston, Massachusetts, United States